ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

DAWN Day One Biopharmaceuticals Inc

17.25
-0.32 (-1.82%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Day One Biopharmaceuticals Inc DAWN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.32 -1.82% 17.25 23:00:06
Open Price Low Price High Price Close Price Previous Close
18.00 17.13 18.00 17.17 17.57
more quote information »

Recent News

Date Time Source Heading
3/07/202415:19EDGAR2Form 8-K - Current report
2/28/202418:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202415:27EDGAR2Form 144 - Report of proposed sale of securities
2/20/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202417:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202416:51EDGAR2Form 144 - Report of proposed sale of securities
1/17/202407:25EDGAR2Form 8-K - Current report
1/09/202418:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202407:30EDGAR2Form 8-K - Current report
1/04/202415:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/17/202317:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202317:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202306:07EDGAR2Form 8-K - Current report
11/16/202317:24EDGAR2Form 144 - Report of proposed sale of securities
11/15/202315:07EDGAR2Form 8-K - Current report
11/06/202315:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202315:30EDGAR2Form 8-K - Current report
10/30/202309:54DJNDay One Biopharmaceuticals Shares Rally on FDA Priority..
10/30/202307:58DJNDay One Gets FDA Priority Review of Tovorafenib in Pediatric..
10/30/202307:12EDGAR2Form 8-K - Current report
10/20/202315:01EDGAR2Form SC 13D/A - General statement of acquisition of..
9/14/202316:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
9/11/202307:35EDGAR2Form 8-K - Current report
8/17/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/17/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/16/202307:06EDGAR2Form 8-K - Current report
8/07/202315:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202315:30EDGAR2Form 8-K - Current report
7/05/202318:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/08/202306:00PRNUSKAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO..

Your Recent History

Delayed Upgrade Clock